Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
hiv
3
×
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
eli lilly
fda
gene editing
gene therapy
gilead sciences
immunomedics
microbiome
novartis
purdue pharma
abbvie
adaptive biotechnologies
What
bio
roundup
moves
week
acquisitions
america
biggest
biogen
biopharma
build
buy
ceo
company’s
congress
congressional
continues
convoluted
crispr
daniel
debut
democrats
dreams
drug
dyne’s
executives
feud
gilead
group
head
headaches
healthcare
holding
insurance
ipo
isn’t
known
later
microbiome
month
new
Language
unset
Current search:
hiv
×
national
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
